Combination therapy with idelalisib better prevents disease progression in relapsed or treatment-resistant chronic lymphocytic leukaemia than current regimen

Study underscores promise of targeted therapies as first-line approach for patients with chronic lymphocytic leukaemia

First targeted therapy for multiple myeloma effective against hard-to-treat disease

First targeted therapy for genetically defined subset of patients with acute myeloid leukaemia significantly improves survival

Exciting evidence for first all-oral treatment for relapsed and treatment-resistant multiple myeloma

Study finds new use for rituximab in acute lymphoblastic leukaemia

First targeted therapy for multiple myeloma effective against hard-to-treat disease

First targeted therapy for genetically defined subset with acute myeloid leukaemia significantly improves survival

Immunotherapy makes patients’ tumours "melt away"

Quality assessment looking at rivaroxaban for cancer-related thrombosis

Tosedostat for elderly acute myeloid leukaemia

Anti-Bcl2 therapy shows promise for relapsed/refractory multiple myeloma